Hims & Hers Health (HIMS) Competitors $49.40 -1.96 (-3.82%) Closing price 10/21/2025 03:59 PM EasternExtended Trading$49.46 +0.06 (+0.12%) As of 07:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, GH, RDNT, BTSG, SHC, OPCH, WGS, GRAL, PRVA, and CELCShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), GRAIL (GRAL), Privia Health Group (PRVA), and Celcuity (CELC). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Its Competitors Natera Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx GRAIL Privia Health Group Celcuity Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.63% 26.26% 13.06% Natera -12.89%-22.22%-15.03% Do insiders and institutionals have more ownership in HIMS or NTRA? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, HIMS or NTRA? Hims & Hers Health has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Which has better valuation & earnings, HIMS or NTRA? Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B7.56$126.04M$0.8061.75Natera$1.70B15.12-$190.43M-$1.91-97.84 Do analysts prefer HIMS or NTRA? Hims & Hers Health currently has a consensus price target of $38.92, suggesting a potential downside of 21.22%. Natera has a consensus price target of $196.81, suggesting a potential upside of 5.31%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Natera 1 Sell rating(s) 1 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 2.89 Does the media prefer HIMS or NTRA? In the previous week, Hims & Hers Health had 38 more articles in the media than Natera. MarketBeat recorded 55 mentions for Hims & Hers Health and 17 mentions for Natera. Natera's average media sentiment score of 0.87 beat Hims & Hers Health's score of 0.66 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 20 Very Positive mention(s) 13 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Natera 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$11.61B$2.26B$6.22B$22.00BDividend YieldN/AN/A5.74%3.61%P/E Ratio61.7537.6729.1432.73Price / Sales7.5616.10589.4461.10Price / Cash145.8461.1937.5124.48Price / Book22.8712.4512.564.67Net Income$126.04M-$64.36M$3.32B$1.02B7 Day Performance-21.32%-3.42%0.73%-0.31%1 Month Performance-14.48%2.46%7.29%-0.17%1 Year Performance109.41%29.16%65.05%11.29% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.3302 of 5 stars$49.40-3.8%$38.92-21.2%+114.3%$11.61B$1.48B61.751,637Trending NewsAnalyst ForecastInsider TradeNTRANatera2.0519 of 5 stars$192.47+5.9%$196.81+2.3%+55.1%$26.40B$1.70B-100.704,434Short Interest ↑GHGuardant Health3.8268 of 5 stars$69.68+6.4%$65.86-5.5%+223.9%$8.70B$739.02M-20.832,021Upcoming EarningsRDNTRadNet3.3995 of 5 stars$78.85+2.5%$76.80-2.6%+19.7%$6.06B$1.83B-394.1811,021News CoverageBTSGBrightSpring Health Services2.1375 of 5 stars$30.26+1.8%$32.13+6.2%+100.4%$5.35B$11.27B97.4235,000Trending NewsEarnings ReportAnalyst ForecastSHCSotera Health2.6021 of 5 stars$16.71+3.4%$17.20+3.0%+6.4%$4.75B$1.10B209.213,000News CoverageOPCHOption Care Health4.7822 of 5 stars$28.21+1.6%$35.10+24.4%-7.5%$4.59B$5.00B22.618,088Positive NewsWGSGeneDx2.7642 of 5 stars$125.82+4.0%$109.78-12.7%+109.3%$3.62B$305.45M2,519.301,200Upcoming EarningsAnalyst ForecastGRALGRAIL0.6776 of 5 stars$91.67+17.5%$56.67-38.2%+477.7%$3.31B$125.60M-7.001,360Trending NewsGap UpHigh Trading VolumePRVAPrivia Health Group3.0522 of 5 stars$26.29+3.0%$28.91+10.0%+46.8%$3.23B$1.74B239.341,140Positive NewsCELCCelcuity1.7776 of 5 stars$70.78+36.2%$62.75-11.3%+306.1%$3.00BN/A-20.4740Trending NewsAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies NTRA Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors OPCH Competitors WGS Competitors GRAL Competitors PRVA Competitors CELC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
